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The lower urinary tract symptoms in patients after 
transurethral resection of benign prostatic hyperplasia
Sergey V. Shkodkin1,2, Nina I. Zhernakova1*, Vadim N. Dmitriev1, Ksenia A. Bocharova1, 
Aleksey V. Polyschuk1, Sergey V. Chirkov1
INTRODUCTION
Urination disorders progress with age and have no 
gender.[1] Despite the fact that, there is no longer 
any doubt about the polyethiologic nature of urinary 
problems in men,[1-3] benign prostatic hyperplasia 
(BPH) is most often serves as the cause of this 
pathology.[2] This is due to the natural correlation of the 
frequency of lower urinary tract symptoms (LUTSs) 
and BPH with the age of patients [Figure 1].[1,3,4]
A powerful pharmacological breakthrough has 
provided us with a wide choice of therapeutic agents 
that affect the various links of the pathogenesis of 
symptoms of the lower urinary tract.[2,5] However, there 
is the category of patients with progression of bladder 
outlet obstruction syndrome on the background of 
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conservative treatment or new patients of urologists 
diagnosed with decompensation of lower urinary tract 
that requires surgical treatment.[6,7]
Transurethral resection (TUR) of the prostate has long 
been recognized as the “gold standard” in the treatment 
of BPH.[8] Despite this, the failure rate after TUR for 
prostate adenoma is high enough so that, according to 
several studies, frequency of long-term persistence of 
post-TUR LUTS may be >30%.[9,10]
Objective of the Research
The objective of this study was to evaluate the long-
term effectiveness of TUR performed in patients with 
BPH.
MATERIALS AND METHODS
We conducted a retrospective analysis of medical 
documentation and the evaluation of the long-term 
effectiveness of TUR performed in patients with 
BPH. The criterion for inclusion in the study was the 
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indication for surgery such as the ineffectiveness of 
conservative therapy in the absence of a large volume 
of residual urine (<50 ml), a period of up to 3 years 
after the TUR; the exclusion criteria were as follows: 
inflammatory changes in the urinary sediment, 
incidental prostate cancer, bladder cancer, urethral 
stricture, and severe cardiovascular decompensation. 
The severity of LUTS was assessed by the results 
of the questionnaire on the international prostate 
symptom score (IPSS) scale and the results of 
ultrasound examination of the lower urinary tract 
and uroflowmetry. In the case of signs of infravesical 
obstruction, patients underwent urethrography.
In addition, to assess the real picture of the possibility 
of examination and treatment of patients with 
neurogenic and non-neural LUTS, a freely available 
survey of urologists was conducted together with 
urological portal UroWeb.ru. The suggested questions 
concerned the diagnosis and treatment of LUTS in 
men and women, as well as in patients with neurogenic 
dysfunction. This review includes issues related to 
bladder hyperactivity in men.
RESULTS AND DISCUSSION
The group included 52 patients at the average age 
of 58.5 ± 6.4 years, according to inclusion and 
exclusion criteria. The prostate volume before the 
operation was within 42.7 ± 13.5 cm3, the volume 
of residual urine was 27.1 ± 17.6 ml and the patients 
had no inflammatory changes in the urine sediment. 
We could not retrospectively evaluate the results of 
IPSS and uroflowmetry, since they were absent in the 
medical records. According to the latter, no serious 
post-operative complications were noted in this group, 
the urethral catheter was removed on day 5.2 ± 1.7 
on average, and the post-operative bed day was 7.8 ± 
2.5 days.
Before surgery, 47 (90.4%) patients received 
medication: 45 (86.5%) of them received monotherapy 
and only two (3.8%) of them received combination 
therapy, including alpha-1-adrenoblocker and 5-alpha-
reductase inhibitor. Among the drugs recommended 
in monotherapy, alpha-1 blockers, which were 
prescribed to 38 (73.1%) patients, were used as the 
unconditional leaders, three (5.8%) patients received 
5-alpha-reductase inhibitor and six (11.5%) took 
herbal drugs. It is noteworthy that the duration of use 
of 5-alpha-reductase inhibitors was 3.6 ± 2.4 months.
The prostate specific antigen (PSA) level in pre-
operative medical documentation was measured in 
41 (78.8%) patients and amounted to 3.8 ± 2.1 ng/
ml. The volume of resected tissue, according to the 
protocols of operations, reached 30.4 ± 10.9 cm3. 
Morphologically, all patients were diagnosed with 
prostate adenoma, 34 (65.4%) histological findings 
indicated the presence of inflammatory infiltration. 
PIN (prostatic intraepithelial neoplasia) was evaluated, 
according to different classifications, the drugs were 
not reviewed and were reduced to the WHO Modified 
Classification, 1989 [Figure 2]. In this case, low-
grade PIN was diagnosed in 24 (46.2%) patients, and 
high-grade PIN was in 13 (25%) patients.
The survey on the IPSS showed that the average score, 
more than a year after TUR, was 14.2 ± 8.5. Only 
15 (28.8%) patients complained of mild symptoms in the 
lower urinary tract, 28 (53.8%) had moderate symptoms, 
and 9 (17.3%) had severe IPSS symptoms [Figure 3].
Instead of the standard question regarding the quality 
of life, we asked our respondents to answer the 
following question: “How do you assess the effect of 
surgical treatment?” They in turn offered the following 
answers: “I am satisfied,” “I have some symptoms 
of the disease,” “I feel worse after the operation.” 
Despite the remaining symptoms in the lower urinary 
tract, more than half, namely, 29 (55.8%) patients 
were satisfied with the effect after TUR of the 
prostate. Another 11 (21.2%) said that the symptoms 
that occurred before the operation regressed. It should 
be noted that 12 (23.1%) patients showed negative 
response to the conducted surgery [Figure 4].
Ultrasound data indicate a significant decrease in the 
volume of the prostate - 19.4 ± 7.7 cm3 relative to 
the initial data of 42.7 ± 13.5 cm3 (P < 0.05), while 
Figure 1: Correlations in the prevalence of benign prostatic hyperplasia, lower urinary tract symptoms, and acute urine 
difficulty, depending on the age of men
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the volume of residual urine, although statistically 
insignificant, increased and amounted to 47.5 ± 
28.3 ml (P > 0.05, [Figure 5].
Urofloumetric examination of patients revealed 
obstructive urination in 8 patients (15.4%), while 
urethrography diagnosed strictures of the bulbous 
urethra [Figure 6]. Moreover, only half of the patients 
in this group negatively assessed the results of TUR, 
three of them reported only a partial preservation of 
the symptoms, and one was completely satisfied with 
the treatment.
Some of patients in a remote post-operative period 
undergo medical treatment for LUTS. At the same time, 
15 (28.8%) continue to take alpha-1-adrenoblockers 
and 5 (9.6%) patients are prescribed a combination 
of the latter with selective M1-cholinolytics, and 
two (3.8%) patients take beta-3-adrenomimetic. The 
dynamics of medication for LUTS is shown in Figure 7.
Evaluating the results of the internet survey, we would 
like to say that the respondents were 48 urologists who 
were directly involved in the diagnosis and treatment 
of LUTS in different categories of patients. This is the 
most active part of the urological community, so the 
interpolation of the sample to the entire population 
will reflect the overall state of affairs. Probably, the 
current state of the problem is even less encouraging.
What do we have in the forefront of urologists 
dealing with the problems of bladder hyperactivity? 
Unfortunately, instrumental diagnostics of 
hyperactivity is available only in 20.3% of the 
treatment facilities where our respondents work, and 
37.5% of urologists need to send patients outside the 
region to undergo integrated urodynamic examination. 
Therefore, medical urgency therapy in men, used 
by 91.7% of urologists involved in the survey, in 
the vast majority of cases is prescribed based on the 
questioning and analysis of various questionnaires.
Figure 2: Compliance of classification of prostatic intraepithelial neoplasia according to D.G. Botswick et al., 1987 and the 
WHO Modified Classification, 1989.
Figure 3: The severity of lower urinary tract symptoms 
according to IPSS survey data in the long-term post-
operative period after transurethral resection of the prostate
Figure 4: Subjective assessment of the effectiveness of 
performed surgical treatment in the long-term post-operative 
period after transurethral resection of the prostate
Figure 5: Ultrasound dynamics in pre- and post-operative 
period. *differences are statistically significant (P < 0.05)
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DISCUSSION
This group of patients has undergone a radical TUR of 
BPH, which is confirmed not only by the volume of 
the removed tissue according to the medical records 
but also by the results of post-operative ultrasound 
monitoring. However, this did not save our patients 
from LUTS, and IPSS survey revealed moderate 
and severe symptoms in 71.1% of the respondents 
[Figure 3]. A subjective evaluation of the results of 
the operation shows slightly better indicators, but the 
percentage of partial and complete dissatisfaction with 
the results is still 44.3% [Figure 4], which requires the 
prescription of pharmacological agents as monotherapy 
and combination treatment in 42.3% of patients. Similar 
results were obtained in other Russian analyzes.[9,10] We 
have not observed correlations between inflammatory 
changes and prostatic intraepithelial neoplasia and the 
frequency of recurrent LUTS.
We would like to focus on the fairly young age of patients 
who had such an indication as the ineffectiveness of 
conservative therapy on the one hand and the relatively 
small volume of the prostate on the other. In addition, 
attention is drawn to the short duration of drug therapy 
and the commitment to a single vector effect on LUTS, 
namely, alpha-1-adrenergic receptors.
A big problem, in our opinion, is the lack of an objective 
diagnosis of detrusor hyperactivity and sphincter state, 
which could limit the pool of even primary patients 
with indications for TUR for BPH. In our opinion, in 
this case, there was a reassessment of the severity of 
infravesical obstruction, which served as an indication 
for surgical treatment. This is also a reason for the 
high percentage of dissatisfaction with the results of 
TUR. A high percentage- 15.4% - of strictures of the 
urethra after TUR for BPH also troubles.
Figure 7: Medication dynamics in pre- and post-operative period.
Figure 6: Uroflourogram (a) and retrograde urethrocystogram (b) of patient Ch. 61-year-old, 3 years after transurethral 
resection (TUR) of the prostate: (a) obstructive type of urination, (b) bulbous stricture (marked with an arrow) and conical 
enlargement of the prostatic urethra after TUR.
a b
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Preservation of LUTS after surgical treatment requires 
careful diagnosis, including the determination of the 
functional state of both detrusor and sphincter of 
the bladder, which most medical institutions cannot 
provide. Without such an approach, it is impossible 
to carry out a qualitative pathogenetic treatment of 
this group of patients, 42.3% of which (those under 
investigation) tend to the necessity of such therapy.
Summary
Young patients with a small volume of residual urine 
are quite a difficult group in terms of performing 
surgical treatment of BPH. TUR in this group of 
patients often does not relieve LUTS and requires 
further medication. The probability of developing 
urethral strictures after TUR adenoma is 15.4%. 
Conduction of functional diagnostics of the lower 
urinary tract will allow to narrow the indications for 
surgery of prostate adenoma, and in the post-operative 
period to choose rational approaches to treatment. 
The introduction of KUDI at least at the bases of 
the regional urological hospitals will outline ways to 
resolve this problem.
REFERENCES
1. Eapen RS, Radomski SB. Review of the epidemiology of 
overactive bladder. Res Rep Urol 2016;8:71-6.
2. Pushkar DI, Rasner PI, Kharchilava RR. Symptoms of the 
lower urinary tract and benign prostatic hyperplasia. Urology 
2016;2:4-19.
3. Speakman M, Kirby R, Doyle S, Ioannou C. Burden of male 
lower urinary tract symptoms (LUTS) suggestive of benign 
prostatic hyperplasia (BPH) - focus on the UK. BJU Int 
2015;115:508-19.
4. Park HJ, Won JE, Sorsaburu S, Rivera PD, Lee SW. Urinary 
tract symptoms (LUTS) secondary to benign prostatic 
hyperplasia (BPH) and LUTS/BPH with erectile dysfunction in 
asian men: A Systematic review focusing on tadalafil. World J 
Mens Health 2013;31:193-207.
5. Dosta NI, Valvachev AA. Benign prostatic hyperplasia: A fresh 
approach to etiopathogenesis and treatment. Prescription 
2007;3:112-21.
6. Lukianov IV, Barantsev DS. Comparative analysis of the 
functional results of retropubic adenomectomy and TUR of the 
prostate. Nat Eng Sci 2012;6:205-8.
7. Li Z, Chen P, Wang J, Mao Q, Xiang H, Wang X, et al. The 
impact of surgical treatments for lower urinary tract symptoms/
benign prostatic hyperplasia on male erectile function: 
A systematic review and network meta-analysis. Medicine 
(Baltimore) 2016;95:e3862.
8. Pranovich AA, Simchenko NI, Voshchula VI. Comparative 
evaluation of the influence of various methods of transurethral 
resection on the hemostatic system in the postoperative period. 
Probl Health Ecol 2010;2:63-6.
9. Iaroshenko VP, Miller AM. Irritative urination disorders after 
transurethral electroresection in patients with benign prostatic 
hyperplasia. Eff Pharm 2011;41:27-8.
10. Lokshin KL, Tangriberganov MR, Gadzhieva ZK. Modern 
possibilities of medication for preserved irritative symptoms 
after TUR of BPH. Eff Pharm 2012;39:24-7.
Source of support: Nil; Conflict of interest: None Declared
